Day: September 2, 2022

Medical device

MDCG 2022-5 – Guidance on borderline medical devices and medicinal products under Regulation (EU) 2017/745 on medical devices

MDCG Guidance documents summary series: MDCG 2022-5 – Guidance on borderline between medical devices and medicinal products under Regulation (EU) 2017/745 on medical devices

2 September 2022

Access the Eclevar Knowledge Center

Why validated Patient Reported Outcomes (PROs) should be used in your PMCF surveys?

Why the PMCF is so crucial under EU MDR?

Insights for the Robust Clinical Evaluation Report (CER) for EU MDR

WEBINAR April 2th, 2025 – Data Matters: Ensuring Quality for Clinical Trial Success

15-Minute Free Consulting

Got a question, an idea, or a project in mind? Get 15 minutes with one of our experts—no strings attached. Just a quick, constructive chat to help you move forward with confidence.

Legal notices

VISIT US

ECLEVAR FRANCE:
231 rue Saint-Honoré, 75001 Paris, France

ECLEVAR GMBH
ERFURT, Erfurt Hauptbahnhof
4th, 5th floor
Bahnhofstr. 38 Erfurt 99084

ECLEVAR Australia
Umina Beach NSW 2257, Australia

ECLEVAR UK Limited
3rd Floor 207 Regent Street, London, W1B 3HH

OUR SERVICES